Actinogen Medical Limited (ASX:ACW)
Australia · Delayed Price · Currency is AUD 0.0550
-0.0010 (-1.79%)
Oct 1, 2026, 3:53 PM AEST
Actinogen Medical Market Cap
Actinogen Medical has a market cap or net worth of 215.48 million as of October 1, 2026. Its market cap has increased by 105.63% in one year.
Market Cap
215.48M
Enterprise Value
203.53M
Revenue
12.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
ChartMarket Cap Chart
Since October 16, 2007, Actinogen Medical's market cap has increased from 12.97M to 215.48M, an increase of 1,561.06%. That is a compound annual growth rate of 15.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 211.63M | 8.86% |
| Dec 31, 2025 | 194.40M | 148.21% |
| Dec 31, 2024 | 78.32M | 54.29% |
| Dec 29, 2023 | 50.76M | -71.90% |
| Dec 30, 2022 | 180.63M | -36.39% |
| Dec 31, 2021 | 283.98M | 832.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 433.68M |
| Starpharma Holdings | 414.86M |
| Racura Oncology | 370.57M |
| Tetratherix | 334.27M |
| BLS Pharmaceuticals | 241.82M |
| Orthocell | 208.33M |
| Paradigm Biopharmaceuticals | 146.80M |
| Dimerix | 138.09M |